Max Healthcare Institute Ltd
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]
- Market Cap ₹ 1,06,882 Cr.
- Current Price ₹ 1,098
- High / Low ₹ 1,302 / 903
- Stock P/E 147
- Book Value ₹ 91.9
- Dividend Yield 0.18 %
- ROCE 10.5 %
- ROE 8.46 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 23.1%
Cons
- Stock is trading at 12.0 times its book value
- Company has a low return on equity of 9.06% over last 3 years.
- Earnings include an other income of Rs.286 Cr.
- Debtor days have increased from 41.8 to 52.9 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 790 | 912 | 984 | 1,059 | 1,008 | 59 | 1,031 | 1,775 | 1,905 | 2,341 | 2,664 | 2,874 | |
| 768 | 890 | 941 | 1,048 | 976 | 65 | 870 | 1,332 | 1,321 | 1,579 | 1,830 | 2,054 | |
| Operating Profit | 22 | 22 | 43 | 11 | 31 | -6 | 161 | 443 | 584 | 762 | 833 | 821 |
| OPM % | 3% | 2% | 4% | 1% | 3% | -10% | 16% | 25% | 31% | 33% | 31% | 29% |
| 33 | 35 | 30 | 51 | 47 | 66 | -104 | 128 | 144 | 271 | 293 | 286 | |
| Interest | 43 | 30 | 35 | 41 | 44 | 60 | 112 | 59 | 52 | 52 | 48 | 40 |
| Depreciation | 49 | 50 | 51 | 49 | 53 | 3 | 91 | 112 | 113 | 117 | 131 | 143 |
| Profit before tax | -38 | -24 | -13 | -28 | -18 | -3 | -146 | 400 | 563 | 865 | 947 | 924 |
| Tax % | 0% | -0% | 0% | 0% | 26% | -5% | 12% | 17% | -23% | 21% | 26% | 22% |
| -38 | -24 | -13 | -28 | -23 | -3 | -164 | 332 | 694 | 687 | 701 | 717 | |
| EPS in Rs | -0.78 | -0.44 | -0.24 | -0.51 | -0.43 | -0.06 | -1.70 | 3.42 | 7.15 | 7.07 | 7.21 | 7.36 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 14% | 21% | 21% | 27% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 23% |
| 3 Years: | 15% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 63% |
| 3 Years: | 2% |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 33% |
| 3 Years: | 22% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 489 | 533 | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 | 973 |
| Reserves | 523 | 762 | 770 | 773 | 749 | 2,338 | 4,973 | 5,342 | 6,071 | 6,709 | 7,317 | 7,967 |
| 296 | 273 | 314 | 386 | 390 | 658 | 480 | 556 | 534 | 443 | 612 | 825 | |
| 141 | 171 | 210 | 278 | 274 | 20 | 724 | 945 | 845 | 945 | 1,065 | 1,125 | |
| Total Liabilities | 1,449 | 1,740 | 1,832 | 1,973 | 1,951 | 3,553 | 7,143 | 7,812 | 8,420 | 9,069 | 9,967 | 10,890 |
| 430 | 424 | 429 | 502 | 479 | 90 | 2,989 | 4,493 | 4,485 | 4,717 | 4,871 | 4,909 | |
| CWIP | 15 | 6 | 30 | 7 | 10 | 0 | 8 | 60 | 103 | 235 | 277 | 509 |
| Investments | 451 | 840 | 866 | 799 | 770 | 2,471 | 2,379 | 1,447 | 1,475 | 1,915 | 2,614 | 2,626 |
| 554 | 469 | 508 | 665 | 693 | 992 | 1,766 | 1,811 | 2,358 | 2,202 | 2,206 | 2,847 | |
| Total Assets | 1,449 | 1,740 | 1,832 | 1,973 | 1,951 | 3,553 | 7,143 | 7,812 | 8,420 | 9,069 | 9,967 | 10,890 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39 | 64 | 33 | 52 | -19 | -36 | 219 | 447 | 696 | 613 | 594 | 503 | |
| -200 | -330 | -66 | -89 | 55 | -2,536 | -84 | -670 | -843 | -806 | -870 | -426 | |
| 176 | 251 | 34 | 36 | -36 | 2,332 | 397 | -161 | -54 | -246 | -28 | 39 | |
| Net Cash Flow | 15 | -16 | 0 | -0 | -0 | -240 | 532 | -384 | -201 | -438 | -304 | 116 |
| Free Cash Flow | -15 | 42 | -47 | -7 | -66 | -39 | 189 | 78 | 579 | 156 | 344 | 153 |
| CFO/OP | 223% | 338% | 93% | 573% | -35% | 467% | 122% | 111% | 134% | 100% | 93% | 86% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 67 | 48 | 55 | 68 | 103 | 517 | 109 | 56 | 27 | 32 | 40 | 53 |
| Inventory Days | 20 | 18 | 19 | 22 | 25 | 33 | 20 | 31 | 24 | 20 | 18 | |
| Days Payable | 171 | 183 | 206 | 250 | 335 | 297 | 159 | 226 | 225 | 186 | 165 | |
| Cash Conversion Cycle | -85 | -117 | -132 | -161 | -206 | 517 | -155 | -83 | -169 | -169 | -125 | -94 |
| Working Capital Days | -15 | -33 | -20 | -27 | 14 | -493 | 27 | 5 | -45 | -32 | -22 | -16 |
| ROCE % | 0% | 1% | 1% | 2% | 2% | 4% | 7% | 9% | 12% | 13% | 10% |
Insights
In beta| Mar 2016 | Mar 2019 | Mar 2020 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Operational Bed Capacity Beds |
|
||||||
| ARPOB (Average Revenue Per Occupied Bed) INR '000 per OBD |
|||||||
| Bed Occupancy Rate % |
|||||||
| Average Length of Stay (ALOS) Days |
|||||||
| Inpatient Volumes (Discharges) Number of patients discharged |
|||||||
| Institutional Patient Bed Share % of bed share |
|||||||
| International Patient Revenue Share % of hospital revenue |
|||||||
| Outpatient Consults Number of consults |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Jul - Regulation 74(5) certificate confirms no demat requests in quarter ended June 30, 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 Jul - Newspaper Publication - Notice of 25th Annual General Meeting and E-Voting Information
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 9 Jul
-
Business Responsibility and Sustainability Reporting (BRSR)
8 Jul - Max Healthcare filed FY 2025-26 BRSR with integrated annual report and assurance statement.
- Reg. 34 (1) Annual Report. 8 Jul
Annual reports
Concalls
-
May 2026Transcript PPT REC
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026Transcript PPT
-
Feb 2026TranscriptPPT REC
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT REC
-
Nov 2025TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT REC
-
Aug 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT REC
-
May 2025TranscriptAI SummaryPPT
-
Feb 2025Transcript PPT REC
-
Jan 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT REC
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024Transcript PPT
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024Transcript PPT
-
Jan 2024TranscriptAI SummaryPPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptAI SummaryPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptAI SummaryPPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
May 2021Transcript PPT
-
Mar 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Feb 2021TranscriptAI SummaryPPT
-
Feb 2021TranscriptAI SummaryPPT
-
Feb 2021TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
Sep 2020Transcript PPT
-
Aug 2020TranscriptAI SummaryPPT
Leadership[1]
The company is India’s largest hospital chain in terms of market cap and 2nd largest hospital in terms of revenue and EBITDA.